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Nicotinamidases catalyze the hydrolysis of the amide bond in nicotinamide (NAM) to
produce ammonia and nicotinic acid (NA). These enzymes are an essential component
of the NAD+ salvage pathway and are implicated in the viability of several pathogenic
organisms. Its absence in humans makes them a promising drug target. In addition,
although they are key analytical biocatalysts for screening modulators in relevant
biomedical enzymes, such as sirtuins and poly-ADP-ribosyltransferases, no commercial
sources are available. Surprisingly, the finding of an affordable source of nicotinamidase
from metagenomic libraries is hindered by the absence of a suitable and fast screening
method. In this manuscript, we describe the development of two new whole-cell
methods using the chemical property of one of the products formed in the enzymatic
reaction (pyrazinoic or NA) to form colored complexes with stable iron salts, such as
ammonium ferrous sulfate or sodium nitroprusside (SNP). After optimization of the assay
conditions, a fosmid polygenomic expression library obtained from deep-sea mesophilic
bacteria was screened, discovering several positive clones with the ammonium ferrous
sulfate method. Their quantitative rescreening with the SNP method allowed the finding
of the first nicotinamidase with balanced catalytic efficiency toward NAM (nicotinamidase
activity) and pyrazinamide (pyrazinamidase activity). Its biochemical characterization has
also made possible the development of the first high-throughput whole-cell method for
prescreening of new nicotinamidase inhibitors by the naked eye, saving time and costs
in the design of future antimicrobial and antiparasitic agents.
Keywords: amidohydrolases, nicotinamidase, functional screening, metagenome, library, high-throughput
screening assays
INTRODUCTION
Nicotinamidases (EC 3.5.1.19) are key metal-dependent amidohydrolases in NAD+ metabolism
of multiple species of archaea (Stekhanova et al., 2014), bacteria (Frothingham et al., 1996; Boshoff
and Mizrahi, 1998; Zhang et al., 2008; French et al., 2010b; Sanchez-Carron et al., 2013), yeast (Joshi
and Handler, 1962; Hu et al., 2007), protozoa (Zerez et al., 1990; Gazanion et al., 2011) and plants
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(Wang and Pichersky, 2007) that catalyze the hydrolysis of
nicotinamide (NAM) (Figure 1A) and its analog pyrazinamide
(PZA) (Figure 1B) to nicotinic acid (NA) or pyrazinoic acid
(POA) and ammonia, respectively. They are also present in
many metazoans such as Drosophila melanogaster (Balan et al.,
2008) and Caenorhabditis elegans (van der Horst et al., 2007),
but absent in mammals, since they alternatively use NAM
phosphoribosyltransferase (NAMPT) to convert NAM directly
to NAM mononucleotide (NMN), which is then recycled to
NAD+ (Opitz and Heiland, 2015). This conspicuous absence of
nicotinamidases in humans makes them a promising drug target,
especially in infections caused by Borrelia burgdorferi (involved
in Lyme disease) (Purser et al., 2003), Brucella abortus (etiological
agent of Malta fever) (Kim et al., 2004), Plasmodium falciparum
protozoa (associated with malarial death) (Zerez et al., 1990)
and Leishmania infantum protozoa (causative agent of infantile
visceral leishmaniasis) (Gazanion et al., 2011), in which this
enzyme has been shown to be essential for the survival of these
pathogenic organisms (Mesquita et al., 2016).
Furthermore, nicotinamidases have become a strategic
focus to be applied as efficient analytical biocatalysts to
determine the activity of various classes of relevant biomedical
enzymes, including NAD+-dependent deacetylases (sirtuins),
CD38 and related glycohydrolases, PARPs and mono-ADP-
ribosyltransferases, PBEF/NAMPT and similar enzymes, such as
NMN adenylyltransferase (NMNAT) and NAM riboside kinase
(NRK) (Hubbard and Sinclair, 2013). Those nicotinamidase-
coupled methods have also been used to identify modulators of
the above classes of enzymes, which are involved in lifespan,
cancer, obesity, and neurodegenerative diseases [for reviews of
such modulators see (Chen, 2011; Chen et al., 2015; Lord et al.,
2015)] as well as to identify levels of NAM, β-NAD, NMN,
and NAM riboside (NR) in clinical samples. However, all these
clinical and analytical applications have been restricted to an
academic environment, since no commercial nicotinamidases
are available, and a simple and inexpensive source of enzyme
has not been found yet. In this sense, functional metagenomics
has arisen as a powerful tool (Mirete et al., 2016), since it
allows, on one hand, the discovery of novel biocatalysts of
uncultured bacteria, thus circumventing traditional methods
that rely on cultivation, and on the other hand, avoids the
major drawback of sequence-based screening technologies, which
do not allow direct conclusions about the functionality and
biochemical parameters of the encoded enzymes. Nevertheless,
functional metagenomics has the important limitation of setting
up function-driven screening assays (Martínez-Martínez et al.,
2015), which in most cases are very tedious and time-consuming,
requiring complex substrates and sophisticated chromogenic
assays as well as high-performance liquid chromatography
(HPLC) or similar analytical methods. Thus, it is not surprising
that the majority of metagenome-derived enzymes that have
been biochemically characterized are mainly esterases/lipases and
glycoside hydrolases (Lopez-Lopez et al., 2014; Sathya and Khan,
2014; Ufarte et al., 2015).
To solve the above-described problems, we report a
combination of two high-throughput screening (HTS) assays,
which are amenable to identify metagenomic nicotinamidases.
FIGURE 1 | Reactions catalyzed by nicotinamidases and their use to
develop a screening method. (A) Nicotinamidase activity toward
nicotinamide (NAM). (B) Pyrazinamidase activity toward pyrazinamide (PZA).
(C) Reaction plate obtained using the pyrazinamide/ammonium ferrous sulfate
(PZA/AFS) method with different recombinant clones. Nicotinamidase clones
were Oceanobacillus iheyensis nicotinamidase (OiNic Wt) and its
corresponding K104A and E65H mutants in pET28a vectors (Sanchez-Carron
et al., 2013). Control wells were E. coli Rosetta 2 transformed with the same
pET empty vector. Color was developed after re-suspending cell pellets in a
mixture of 20 mM PZA and 1% AFS for 1 h at 37◦C.
The first assay is based on a modification of an already known
method (Wayne, 1974), which consists of the incubation of
whole cells with PZA and ammonium ferrous sulfate (AFS), and
allows a rapid and perfect contrast between positive and negative
clones, even with the naked eye. In addition, the second assay
is a new whole-cell method based on a different stable iron salt,
sodium nitroprusside (SNP). This latter method is able to detect
clones not only with high activity toward PZA, but also toward
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NAM. Using the first method, we have screened a fosmid library
with 8000 clones obtained from mesophilic marine bacteria
(MB polygenomic library) and thereby identified some positive
clones that showed significant pyrazinamidase activity. These
positive clones were rescreened with the second method, finding
a novel enzyme designated as PolyNic, which was highly active
toward PZA, NAM and its analogs, and for the first time ever,
with balanced nicotinamidase and pyrazinamidase activities.
Finally, after its biochemical characterization, the first method
was also optimized for qualitative screening of new possible
nicotinamidase inhibitors.
MATERIALS AND METHODS
Strains, Plasmids, and Chemicals
Escherichia coli EPI300-T1 (Epicentre, Madison, WI, USA) was
used for the screening of the genomic libraries cloned in
pCC1FOS fosmids library (Epicentre). E. coli strain Rosetta 2
(DE3) was used as the host for pET46 Ek/LIC expression vector.
Nicotinamidase substrates, inhibitors, and stable iron salts were
obtained from Sigma-Aldrich.
Genomic DNA Libraries
Fosmid library contained inserts of mixed genomic DNA of 194
mesophilic bacteria (MB) isolated from deep-sea hydrothermal
vents sampled at various sites in Mid Atlantic Ridge. The DNA
extracted from individual isolates was pooled in equal ratios
and used to prepare a polygenomic library using Epicentre
Fosmid Library Construction Kit (Epicentre), according to the
manufacturer instructions and as described earlier, to produce a
library named MB (Leis et al., 2015). The fosmids clones in E. coli
EPI300-T1 were arrayed in 384-well microtiter plates and stored
at−80◦C in LB with chloramphenicol (12.5 µg/mL).
Functional Screening
To detect pyrazinamidase activity in the fosmid constructions
of the polygenomic libraries, we used a modification of the
Wayne’s pyrazinamidase assay (Wayne, 1974). This method is
based on the complex formed between AFS and POA formed
in the pyrazinamidase reaction, giving rise to an intense red
color. Briefly, Escherichia coli EPI300-T1 transformed with the
fosmid library was grown on LB agar plates at 37◦C overnight
to yield single colonies, which were stored in 384-well plates
with LB and chloramphenicol (12.5 µg/mL) at −80◦C. Replica
plating was used to transfer the library colonies to 96-well plates
containing 200 µL of fresh LB with the same antibiotic and
Fosmid Autoinduction Solution (Epicentre, Madison, WI, USA)
for activation of the oriV origin and hence for increasing of
fosmids copy number per cell. After growing at 37◦C overnight,
their pellets were then re-suspended in a mixture of 20 mM
PZA and 1% AFS dissolved in MilliQ R© water, and incubated
for 1 h at 37◦C until an intense red color appeared. If desired,
the revealed plates could be incubated overnight to obtain
an even more intense red color with no appreciable change
in control wells. Positive and negative controls were made
using previously cloned Oceanobacillus iheyensis nicotinamidase
(OiNic) (Sanchez-Carron et al., 2013) and empty EPI300-T1 cells,
respectively.
To detect pyrazinamidase or nicotinamidase activity using
SNP, culture conditions were the same as in the previous method
(AFS method), but pellets were re-suspended in 1 mM PZA
or NAM with 0.75% SNP. Once re-suspended, plates were
incubated at 37◦C for 4 h, centrifuged, and the supernatants were
transferred to flat 96-well plates. The difference in absorbance
between the negative control wells and those containing the
fosmids clones was measured at 495 or 395 nm, to detect
pyrazinamidase or nicotinamidase activity, respectively.
Sequence Analysis
Positive clones were selected and their DNA inserts were
sequenced using a Roche 454 GS FLX Ti sequencer (454
Life Sciences, Branford, CT, USA) at Life Sequencing SL
(Valencia, Spain). Upon completion of sequencing, the reads were
assembled to generate non-redundant meta-sequences using
Newbler GS De Novo Assembler v.2.3 (Roche). The GeneMark
software (Lukashin and Borodovsky, 1998) was employed to
predict potential protein-coding regions (open reading frames
(ORFs) with ≥20 amino acids) from the sequences of each
assembled contig, and deduced proteins were screened via blastp
and psi-blast (Altschul et al., 1997). ESPript (Robert and Gouet,
2014) was used for displaying alignments. PolyNic homology
modeling was carried out with Swiss-Model1 (Biasini et al.,
2014) using Pyrococcus horikoshii nicotinamidase coordinates
as template (PhNic, PDB 1IM5), and structurally aligned with
Chimera (Pettersen et al., 2004).
Cloning, Expression, and Purification
The selected positive gene of the fosmid library (contig
00048_2428, NCBI’s BioSample accession: SAMN05386332
and NCBI’s Sequence Read Archive accession: SRP079696),
named as PolyNic, was amplified by PCR with a high fidelity
thermostable DNA polymerase (Pfu UltraII Fusion HS, Agilent).
The respective forward and reverse oligonucleotides were 5′-
ATGGAAATAAAGGAGAAATTCACCGTGTCGCCAACTCTC
CATTATCAACCTAATGACGCG-3′ and 5′-CTACTGGTCGTG
GACATGCAACGCGACTTCTGCGAAGGCGGAGCTCTGGC
GATTGATGGC-3′. The amplified PCR product (588 bp) was
inserted into pET-46 Ek/LIC vector (EMD Millipore). The
vector was later transformed into E. coli Rosetta 2 (DE3). Cells
were grown in 1 L of Terrific Broth (TB) supplemented with
ampicillin (50 µg/mL) and chloramphenicol (12.5 µg/mL) and,
when the OD600 reached a value of 4, induced with 0.5 mM
isopropyl-β-thiogalactoside (IPTG) for 16 h at 25◦C with
constant agitation. Cells were harvested by centrifugation,
re-suspended in lysis buffer (50 mM sodium phosphate buffer
pH 7.3 containing 300 mM NaCl) and disrupted using a Bead
Beater (BioSpec, USA). The protein in the supernatant was then
purified by Ni2+-chelating affinity chromatography (ÄKTA
Prime Plus, GE Life Sciences) onto a HiPrep IMAC 16/10 FF
20 mL column (GE Life Sciences). Fractions containing the
desired protein were desalted, concentrated and filtrated onto
1https://swissmodel.expasy.org/
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a Superdex 200 HiLoad 16/600 column (GE Life Sciences),
obtaining an electrophoretically pure enzyme. The protein
molecular mass was determined by SDS-PAGE, gel filtration
and using an HPLC/ESI/ion trap system (Sanchez-Carron et al.,
2011). Protein concentration was determined using Bradford
reagent (Bio-Rad) and BSA as standard.
Enzyme Assay
Nicotinamidase activity was determined chromatographically by
HPLC following the increase in the NA area, using an HPLC
(Agilent 1100 series) with a reverse-phase C18 250 mm× 4.6 mm
column (Gemini C18, Phenomenex) and a mobile phase (20 mM
ammonium acetate pH 6.9) running at 1 mL/min. Under these
conditions, the retention times (RT) for NA and NAM were
7 and 19.9 min, respectively. The standard reaction medium
consisted of 1 mM NAM and 0.14 µM of purified PolyNic in
100 mM phosphate buffer at pH 7.3. Reactions were stopped
by the addition of trifluoroacetic acid to 1% (v/v). One unit of
activity was defined as the amount of enzyme required to cleave
1 µmol of NAM releasing 1 µmol of NA in 1 min. The activity
toward other NAM analogs was also determined by HPLC.
Finally, the inhibition constants toward nicotinaldehyde and 5-
bromo-nicotinaldehyde were obtained as previously described
(Sanchez-Carron et al., 2013).
RESULTS
Screening Assay Development
In order to establish a simple whole-cell method for
nicotinamidases, the first step was to test the two previously
described methods for detecting pyrazinamidase activity with
POA and AFS. In the first method, used for detecting PZA
activity in Enterobacteriaceae, a wireloop of an overnight
bacterial culture on Tryptic Soy Broth is suspended in 0.2 mL
of a 0.5% PZA solution, incubated for 18 h at 37◦C, and
finished by the addition of two drops of a 1% freshly prepared
AFS solution to the culture (Pignato and Giammanco, 1992).
In the second method, E. coli cells are cultured overnight in
LB containing 8 mM PZA, centrifuged for 3 min at 13800 g,
washed twice with 150 mM NaCl in 100 mM Tris-HCl pH
7.5, re-suspended in 8 mM with PZA, incubated at 37◦C for
120 min, centrifuged again, revealed with 0.05 volumes of
500 mM AFS and, finally, the change in OD480 compared
with a standard curve (Frothingham et al., 1996). However,
when both methods were tested with a previously cloned
O. iheyensis nicotinamidase (OiNic) in E. coli Rosetta 2
(Sanchez-Carron et al., 2013), several drawbacks came out. In
the first method, the interferences produced with the culture
medium gave faint and not very reliable colors, whereas in the
second, the need of several steps, centrifugations and, especially
the precipitation of POA-ferrous ion complex at pH > 6
hinders the correct spectrophotometric quantification. Thus, a
more simple method suitable for HTS was developed by just
resuspending the LB overnight OiNic E. coli pellets in a solution
with 20 mM PZA and 1% AFS dissolved in MilliQ R© water at
37◦C. The red color corresponding to POA/AFS complex was
developed faster than in the above-described methods, just in
1 h (Supplementary Figure S1A), being this color even more
intense after an overnight incubation, without any discernible
color in control wells (Supplementary Figure S1B). Thus, to
minimize the time of the assay for HTS, a clone that gave red
color after 1 h was considered as a pyrazinamidase positive
clone.
To test the sensitivity of the assay, the method was tested
with different OiNic mutants (Sanchez-Carron et al., 2013). Clear
differences between wild-type (OiNic Wt), K104A (total loss of
activity), and E65H (less activity than the wild-type) mutants
were observed, giving rise to a gradient of colors, depending on
how such mutation affects the activity (Figure 1C). Nevertheless,
when NAM is used for this screening instead of PZA, it is
difficult to discriminate between more or less active clones, since
a faint orange color is formed inside cells and not in the reaction
medium (data not shown), making impossible to discriminate
between them and control cells, even after centrifugation and
subsequent detection in a microplate spectrophotometer.
Thus, only nicotinamidases with activity toward PZA could
be screened with the AFS method. To circumvent this limitation,
another activity assay was developed to be also used with NAM,
using a different stable iron salt, SNP. This salt at neutral-
basic pHs not only reacted with POA (Figure 2, curve A;
ε475nm = 4374 M−1 cm−1) but also with PZA (Figure 2,
curve B; ε495nm = 4549 M−1 cm−1). Surprisingly, it also
gave appreciable color with both NAM (Figure 2, curve C;
ε395nm = 3125 M−1 cm−1) and its corresponding acid (NA)
(Figure 2, curve D; ε385nm = 2688 M−1 cm−1). To explore these
different reactions (colors) of nicotinamidase substrates/products
with SNP, which have never been used for whole-cell screening
of this enzyme, different optimization conditions were tested
with NAM and PZA as substrates. Since the change in color in
the PZA/SNP method from red to orange was more evident,
FIGURE 2 | Absorbance spectra obtained with nicotinamidase
substrates and products in presence of sodium nitroprusside (SNP).
(A) Pyrazinoic acid-nitroprusside complex. (B) PZA-nitroprusside complex.
(C) NAM-nitroprusside complex. (D) Nicotinic acid-nitroprusside complex. All
nicotinamidase substrates and products were at 0.25 mM and SNP at 0.75%
(w/v).
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FIGURE 3 | Optimization of the whole-cell SNP method. (A,B) PZA as substrate. (A) PZA was kept constant at 0.3 mM while SNP concentration was changed.
(B) PZA concentration was modified at 0.75% SNP. (C,D) NAM as substrate. (C) NAM was kept constant at 0.3 mM while SNP concentration was adjusted.
(D) NAM concentration was modified at 0.75% SNP. OiNic Wt clones are shown in black and control clones in gray.
we started to optimize conditions with it. In order to see the
decrease in the color of the wells with the naked eye, lower
concentrations of PZA were needed (Figure 3A), when compared
with the PZA/AFS method. At 0.3 mM PZA, the difference in
color between OiNic Wt (Figure 3A, squares) and control clones
(Figure 3A, circles) was more evident at 0.75% SNP. Once the
SNP concentration was adjusted, different concentrations of the
substrate were tested at 0.75% SNP in order to get the highest
resolution. The difference in absorbance at 495 nm increased
with PZA concentration up to 1 mM (about 0.2 absorbance
units), tending toward a plateau (Figure 3B). On the other hand,
the differences in the case of NAM were less evident by the
naked eye due to the change in color from yellow to pale yellow,
but still spectrophotometrically measurable. Again, 0.75% SNP
(Figure 3C) and 1 mM NAM (Figure 3D) gave the best color
contrast at 395 nm (also about 0.2 absorbance units). However,
whereas substrate concentrations were decreased down to 1 mM
in the SNP method, the revealing time increased up to 4 h to see
measurable differences in color.
Collectively, these results show that this new SNP assay could
be used as a re-screening method in order to find not only
highly active pyrazinamidases, but also to easily distinguish
among more or less active nicotinamidases in a quantitative
(spectrophotometric) way.
Screening of Metagenomic Libraries
Once the two new whole-cell screening methods were optimized
with a known nicotinamidase (OiNic) (Sanchez-Carron
et al., 2013), a fosmid library obtained from mesophilic MB
polygenomic library was first screened with the PZA/AFS
method. After induction with the autoinduction solution
(Epicentre, USA) (Supplementary Figure S2), only 8 over 8832
fosmid clones screened were positive with a different degree of
activity, as shown by their different color intensity (Figure 4A).
These clones were then re-screened with NAM (Figure 4B, black
bars) and PZA (Figure 4B, gray bars) with the SNP method,
confirming not only the presence of pyrazinamidase activity but
also its correlation with the nicotinamidase activity.
Clear differences between clones with respect to both activities
were observed (Figure 4B), and for a proof-of-principle, one of
the clones with similar high nicotinamidase and pyrazinamidase
activity (Figure 4B; L24 M14) was selected to be sequenced,
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FIGURE 4 | Screening of mesophilic marine bacteria (MB) polygenomic library. (A) Positive fosmid clones found in MB polygenomic library with the PZA/AFS
method. (B) Positive fosmid clones found in MB polygenomic library rescreened with the SNP method with NAM (black bars) and PZA (gray bars) as substrates.
Legends below bars reflect the position of the positive clones in their corresponding master plates. Negative controls (C−) are empty control cells (E. coli EPI300-T1
cells).
since it showed the most balanced decrease in absorbance
with both substrates compared to the control. BLAST analysis
of the amino acid sequence obtained from this polygenomic
nicotinamidase (PolyNic) (Figure 5) showed a 91% identity
with a nicotinamidase found in Halomonas sp. HL-48 (UniProt
code: A0A0P7YXE9). In addition, PolyNic also showed variable
similarity (25–46%, Supplementary Table S1) with the crystallized
nicotinamidases found in the bibliography (Figure 5) (Du et al.,
2001; Hu et al., 2007; Fyfe et al., 2009; French et al., 2010a;
Gazanion et al., 2011; Liu et al., 2011; Petrella et al., 2011).
The alignment also revealed that PolyNic contained all the
conserved catalytic triad residues of the cysteine-hydrolases
family (Figure 5, filled circles): a catalytic cysteine at position
150 (C150, PolyNic numbering), an aspartate at position 25
(D25) and a lysine at position 111 (K111) (French et al.,
2010b; Sanchez-Carron et al., 2013; Ion et al., 2014; Sheng and
Liu, 2014). Furthermore, PolyNic showed the characteristic cis-
peptide bond (Figure 5, positions L145 and A146, filled squares),
which is invariably preceded by a conserved glycine (G144), and
the conserved specific metal ion binding, which includes one
aspartate (D67) and two histidines (H69 and H86) (Figure 5,
filled triangles). Depending on the metal ion and on the structural
conformation of the protein, a fourth residue may be implicated
in the metal ion binding (Sanchez-Carron et al., 2013). This
residue can be a glutamic acid, a histidine or a serine, being the
last one the case of PolyNic (S75). Other residues also involved
in the formation of the hydrophobic cavity, where NAM and the
ion metal bind (Zhang et al., 2008; Sanchez-Carron et al., 2013)
are also present in PolyNic, such as F30, L36, W83, A112, Y120,
and V149 (Figure 5, filled stars; Supplementary Table S2).
Substrate Specificity and Kinetic
Parameters
PolyNic functional characterization was carried out after cloning
its sequence into pET46 Ek/LIC vector. The recombinant clone
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FIGURE 5 | Multiple sequence alignment between PolyNic and related crystallized nicotinamidases. Strictly conserved residues have a red background
and similar residues are marked with a blue square. Springs and arrows represent helices and strands of the secondary structure, respectively. Strict β-turns are
represented as TT. Important residues for catalysis ( ), cis-peptide bond (), metal ion binding (N) and the hydrophobic cavity where NAM and metal ion bind are
also indicated (H). Four letter codes in the name of the sequences are PDB codes.
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FIGURE 6 | Effect of pH and temperature on PolyNic activity. (A) pH
profile. Assay conditions were 1 mM NAM and 0.14 µM PolyNic in different
100 mM buffers at 37◦C. Buffers used were sodium acetate pH 4.0–5.0,
sodium phosphate pH 6.0–7.3, Tris-HCl pH 8.0, glycine pH 9.0–10.0, CAPS
pH 10.5–11.0. (B) Temperature profile. Assay conditions were the same as
above but at pH 7.3 and different temperatures (10–90◦C).
with the highest expression was induced with 0.5 mM IPTG
for 16 h at 25◦C in TB medium with constant agitation and
purified to homogeneity from Escherichia coli Rosetta 2 DE3
cells by a simple procedure based in a Ni2+-chelating affinity
chromatography and a gel filtration step onto a Superdex 200, as
described in the “Materials and Methods” Section. The molecular
mass of the purified protein was determined by SDS-PAGE
(∼23 kDa), HPLC/ESI/ion trap (24.1 kDa) and gel filtration in a
Superdex 200 10/300 GL column (50.3 kDa). These experiments
confirmed its dimeric nature.
The enzyme activity was both pH- and temperature-
dependent. The activity increased as pH increases from pH 5.0
to pH 10.0 (Figure 6A), being the first nicotinamidase described
with its optimal activity at that basic pH, since the highest
optimum pH described in the bibliography was pH 8.0 for
the Lactobacillus arabinosus 17-5 nicotinamidase (Hughes and
Williamson, 1953). PolyNic exhibited its maximum activity at
a temperature of 50◦C (Figure 6B), which is 5 to 20◦C higher
than those described for other nicotinamidases (Pardee et al.,
1971; Yan and Sloan, 1987; Zhang et al., 2008; Sanchez-Carron
et al., 2013). However, and for comparison purposes, kinetic
parameters were carried out at pH 7.3 and 37◦C, as generally
accepted in the bibliography (Zhang et al., 2008; French et al.,
2010b; Sanchez-Carron et al., 2013).
The activity of PolyNic was studied toward NAM and
some of its derivatives (Table 1), which include PZA, 5-
methylnicotinamide and two nicotinate esters (methylnicotinate
and ethylnicotinate). PolyNic showed a quite similar catalytic
efficiency for PZA (kcat/KM 69.9 mM−1s−1) and for NAM
(kcat/KM 102.0 mM−1 s−1). Thus, PolyNic is the first described
bacterial nicotinamidase with these characteristics, since the rest
of characterized nicotinamidases have a marked preference for
NAM instead of PZA (more difference between their catalytic
efficiencies), including that of Mycobacterium tuberculosis
(Zhang et al., 2008; French et al., 2010b; Sanchez-Carron et al.,
2013). Furthermore, PolyNic also showed activity toward 5-
methylnicotinamide, although with a lower catalytic efficiency
(kcat/KM 18.9 mM−1 s−1) compared to NAM and PZA, but
it was still 2.5-fold higher than that described before for
OiNic (kcat/KM 7.5 mM−1 s−1) (Sanchez-Carron et al., 2013).
Interestingly, the enzyme was active toward methylnicotinate
(kcat/KM 19.7 mM−1 s−1), with the highest ever-described
catalytic efficiency. In fact, PolyNic is 293-fold more active
toward methylnicotinate than OiNic (Sanchez-Carron et al.,
2013). Finally, ethylnicotinate was a very poor substrate for
PolyNic (kcat/KM 1.0 mM−1 s−1) as usual in this kind of
enzymes, but still ninefold higher than for OiNic (Sanchez-
Carron et al., 2013).
Applicability of the Whole-Cell
High-Throughput Screening for Inhibitor
Testing
Nicotinaldehydes have been reported to act as good competitive
inhibitors for several nicotinamidases (French et al., 2010b;
Sanchez-Carron et al., 2013). Thus, recombinant PolyNic
was tested with nicotinaldehyde and 5-bromo-nicotinaldehyde,
toward both substrates, NAM (Figure 7A) and PZA (Figure 7B),
respectively. The K i value for nicotinaldehyde with NAM was
found to be 0.18 µM (Figure 7A; circles), a similar value to that
found in Borrelia burgdorferi nicotinamidase (0.11 µM) (French
et al., 2010b). The K i value for 5-bromo-nicotinaldehyde with
NAM was higher (0.72 µM) (Figure 7A; squares) than that of
nicotinaldehyde, and similar to that found for the Plasmodium
falciparum nicotinamidase (0.57 µM) (French et al., 2010b).
TABLE 1 | Kinetic parameters of PolyNic toward different substrates.
Substrate Km, µM kcat, s−1 kcat/Km, mM−1 s−1
Nicotinamide (NAM) 49 ± 2 5.0 ± 0.1 102.0
Pyrazinamide (PZA) 103 ± 10 7.2 ± 0.2 69.9
5-methyl-NAM 435 ± 15 8.2 ± 0.5 18.9
Methylnicotinate 355 ± 30 7.0 ± 0.4 19.7
Ethylnicotinate 1092 ± 105 1.1 ± 0.1 1.0
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FIGURE 7 | Inhibition of PolyNic by nicotinaldehydes. (A) Inhibition of
PolyNic by nicotinaldehyde ( ) and 5-bromo-nicotinaldehyde () using NAM
as substrate. (B) The same as (A) but with PZA as substrate. Reactions were
carried out at 37◦C, 1 mM substrate (NAM or PZA) and 0.14 µM PolyNic in
100 mM phosphate buffer pH 7.3. Morrison’s equation was used to fit data
and to obtain the K i values, as previously described (Sanchez-Carron et al.,
2013).
Interestingly, the K i values for nicotinaldehyde and 5-bromo-
nicotinaldehyde obtained with PZA were 0.015 and 0.07 µM,
respectively (Figure 7B), which are much lower than those
obtained using NAM as substrate. These values could not be
compared since no data on nicotinaldehyde inhibition with PZA
have been published.
With the K i values described above, our goal was to
develop the first whole-cell screening method for testing
nicotinamidase inhibitors using the PZA/AFS and NAM/SNP
methods. Thus, different concentrations of nicotinaldehyde and
5-bromo-nicotinaldehyde (0–1500 µM) were added to each well
inoculated with PolyNic in E. coli Rosetta 2 before adding the
revealing solution (20 mM PZA/1% AFS or 1 mM NAM/0.75%
SNP). Surprisingly, SNP was not suitable for inhibitor screening
because the difference of absorbance between the untreated and
the treated wells was not enough to rely on this method with
both substrates. Furthermore, at the highest concentration of
FIGURE 8 | Inhibitor testing using the new whole-cell screening
method. Nicotinamidase aldehyde inhibitors, nicotinaldehyde (A) and
5-bromo-nicotinaldehyde (B) were assayed with the PZA/AFS method. E. coli
Rosetta 2 cells containing pET46b-PolyNic vector were incubated in presence
of 20 mM PZA and 1% AFS for 1 h at 37◦C with different inhibition
concentrations.
the inhibitors, the absorbance was greater than expected in
comparison with the other wells, probably because of a reaction
between SNP and the inhibitors themselves (data not shown).
However, in the case of the AFS method, it was possible to
find a gradient of colors (from red, orange to uncolored) as the
inhibitor concentration rose (Figure 8), finding by the naked
eye that nicotinaldehyde (Figure 8A) is a better inhibitor than
5-bromo-nicotinaldehyde (Figure 8B), since color formation
stops at lower concentrations with nicotinaldehyde (75–100 µM)
than with 5-bromo-nicotinaldehyde (250–500 µM) (Figure 8),
which correlates well with the above-described kinetic results.
These results make this whole-cell PZA/AFS assay a simple HTS
qualitative prescreening method for nicotinamidase inhibitors.
DISCUSSION
Nicotinamidase activity is usually followed by reverse phase
HPLC using its natural substrate (NAM), or continuously
monitored following one of the two products of the
nicotinamidase reaction (ammonia) in a coupled assay
with bovine or recombinant glutamate dehydrogenases
(GDH) (French et al., 2010b; Sanchez-Carron et al., 2013).
These latter enzymes catalyze the reaction of α-ketoglutarate,
ammonia, and NAD(P)H to form glutamate and the oxidized
dinucleotide with the concomitant decrease in absorbance
(ε340 = 6200 M−1 cm−1). While the latter method could
be adapted for HT screening, it is not suitable for screening
large metagenomic or directed evolution libraries, due to
the coupled enzyme costs. To solve the above-mentioned
problems, a new whole-cell method is proposed based on
the substrate promiscuity of nicotinamidases. In fact, these
enzymes are also able to use NAM derivatives, including PZA
(Figure 1B). This latter compound was first commercialized
with the name of Aldinamide by Lederle Laboratories (American
Cyanamid, Wayne, NY, USA) for the treatment ofMycobacterium
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tuberculosis infections. In combination with isoniazid (INH) and
rifampin, PZA allowed the conventional 9-month tuberculosis
treatment regimen to be shortened to 4–6 months (Aldrich et al.,
2010). This pro-drug is converted into POA by Mycobacterium
tuberculosis nicotinamidase (Kalinda and Aldrich, 2012). In
order to determine blood and urine levels of the drug, a simple
colorimetric method was developed, in which an orange–red
complex with a maximum absorbance at 480 nm is formed in
the presence of AFS (also known as Mohr’s salt) after PZA in the
blood extract was hydrolyzed with alkali to the corresponding
salt of POA (Allen et al., 1953). This reaction was later applied
to determine PZA deamidase activity in animal tissues and to
perform PZA susceptibility tests in Mycobacterium tuberculosis
strains at acid pH, even when such microorganism does not grow
well at pH 5.5, giving rise, in some cases, to inconsistent results
between different labs (Wayne, 1974; Martin et al., 2006; Chang
et al., 2011). To reduce these contradictory results, a method was
developed using in vitro synthesized pyrazinamidases (PZases)
obtained after PCR amplification of pncA gene of different
Mycobacterium strains with their concomitant expression in a
wheat germ system, followed by colorimetric detection of the
corresponding POA generated with AFS (Zhou et al., 2011;
Li et al., 2014). However, the latter multi-step method is not
suitable for HTS. In addition, the two previously reported
whole-cell methods described for detecting nicotinamidase
activity (Pignato and Giammanco, 1992; Frothingham et al.,
1996), when tested with a previously cloned O. iheyensis
nicotinamidase (OiNic) in E. coli Rosetta 2 (Sanchez-Carron
et al., 2013), showed several drawbacks. In the first method
(Pignato and Giammanco, 1992), the interferences produced
with the culture medium gave faint and not very reliable colors,
whereas in the second (Frothingham et al., 1996), the need of
several steps, centrifugations and, especially the precipitation
of POA-ferrous ion complex at pH > 6 hinders the correct
spectrophotometric quantification. Thus, a more simple and
fast (just in 1 h, Supplementary Figure S1A) method suitable
for HTS was developed by just resuspending the LB overnight
OiNic E. coli pellets in a solution with 20 mM PZA and 1%
AFS dissolved in MilliQ R© water at 37◦C. The intensity of the
color in the wells was also related to the activity expressed by
the cells. A gradient of colors was observed between wild-type
(OiNic Wt), K104A (total loss of activity), and E65H (less
activity than the wild-type) mutants (Figure 1C). However, such
differences in color were unreliable when NAM was used as
substrate for this screening instead of PZA, making impossible
to discriminate between mutants and control cells, even after
centrifugation, and subsequent detection in a microplate
spectrophotometer.
This limitation for screening enzymes highly active toward
NAM as substrate was solved using SNP, which reacts
with both substrates (NAM and PZA) and also with both
products (NA and POA) (Figure 2), but giving complexes
with different absorption coefficients. These differences
in color could be easily followed spectrophotometrically,
giving rise to a new method that is able to quantify both
nicotinamidase and pyrazinamidase activities of a selected
clone.
These two new whole-cell screening methods were tested
sequentially with a polygenomic library (8832 fosmid clones)
for a proof-of-principle. Among the 8 positive clones obtained
(Figure 4A), the one with the highest activity toward both
substrates was selected (Figure 4B; L24 M14) to be sequenced,
showing all the conserved amino acids of an authentic
nicotinamidase (Figure 5). When this enzyme, named as PolyNic,
was kinetically characterized, it showed the lowest ratio described
in bibliography between catalytic efficiency for NAM and for
PZA (1.5). This ratio is far from those described for the
nicotinamidases of Mycobacterium tuberculosis (17.5) (French
et al., 2010b), Oceanobacillus iheyensis (13.5) (Sanchez-Carron
et al., 2013), and Saccharomyces cerevisiae (4.4) (French et al.,
2010b). These balanced activities convert PolyNic into a flexible
biocatalyst for use in analytical kits for the determination of
sirtuin activity and in tests for finding new pro-drug NAM
derivatives to treat infections caused by the pathogenic organisms
described in the “Introduction” section.
In addition, when PolyNic was modeled with SwissModel
using Pyrococcus horikoshii nicotinamidase coordinates as
template (PhNic, PDB 1IM5) and structurally aligned with
another two crystallized nicotinamidases with a serine as the
fourth amino acid involved in metal-binding (e.g., Acinetobacter
baumannii (AbNic, 2WT9) and Pyrococcus horikoshii (PhNic,
1IM5) nicotinamidases), the only difference found in the active
center was the presence of a valine residue (V149 in PolyNic)
rather than a phenylalanine (F158 in AbNic) or a tyrosine
(Y132 in PhNic) (Figure 5, filled stars; Supplementary Figure
S3; Supplementary Table S2). The absence of an aromatic ring
at this position of the active center might be responsible for
the balanced catalytic efficiency. However, more data are needed
to test this hypothesis, since no catalytic efficiencies for both
substrates have been described for AbNic and PhNic so far (Du
et al., 2001; Fyfe et al., 2009). In fact, only AbNic catalytic
efficiency for NAM is known (0.48 mM−1 s−1), having been
found to be 212-fold lower than that of PolyNic. The latter
enzyme (PolyNic) has also higher catalytic efficiency than the
Saccharomyces cerevisiae PNC1 nicotinamidase (French et al.,
2010b), which is the most used nicotinamidase in enzyme-
coupled assays for identifying new sirtuin modulators (Hubbard
and Sinclair, 2013) as possible pharmaceuticals in lifespan,
cancer, obesity and neurodegenerative diseases. Thus, PolyNic
could be a clear biotechnological alternative for a commercial
nicotinamidase due to its high activity and expression, together
with its simple and efficient purification procedure.
The kinetic characterization of PolyNic has also allowed
us to develop the first high-throughput whole-cell method for
prescreening of new nicotinamidase inhibitors by the naked
eye. In this case, only the qualitative PZA/AFS method was
reliable, finding that nicotinaldehyde (Figure 8A) is a better
inhibitor than 5-bromo-nicotinaldehyde (Figure 8B), since color
formation stops at lower concentrations with nicotinaldehyde,
and supporting the kinetic data obtained (Figure 7).
Finally, the screening methods described in the present paper
could be further optimized by changing the salts used to form
the complexes with the enzyme substrates/products. For this,
different divalent ions, such as cobalt, nickel or copper could
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be used. However, the type of salt has to be taken into account
since, for example, the above metal ions in their perchlorate forms
give insoluble complexes with POA (Magri et al., 1980). On the
other hand, SNP could be replaced with a similar stable ferrous
salt, such as potassium ferrocyanide, although the conditions
(concentrations, time, etc) have to be optimized in the same way
as described in the present paper. Further research is needed to
find new complexes with NAM and PZA with the ultimate aim
of developing a cheap and reliable PZA susceptibility test for the
different Mycobacterium tuberculosis strains.
Interestingly, the SNP method could also be used to assay
other enzymatic activities besides nicotinamidases. In fact, this
method could permit the detection of new inhibitors of two
enzymes, which are currently targets in cancer therapy (Cerna
et al., 2012; Duarte-Pereira et al., 2016) – the human NAMPT (EC
2.4.2.12) and the nicotinate phosphoribosyltransferase (NaPRT)
(EC 6.3.4.21), which use NAM and NA as substrates to convert
them into NMN and nicotinic acid mononucleotide (NaMN),
respectively. These enzymatic reactions produce a β-N-glycosidic
bond with the pyridine nitrogen of both NAM and NA in
presence of phosphoribosyl pyrophosphate (PRPP) and ATP. The
absence of this nitrogen donor in the pyridine ring of NMN
and NaMN hinders the formation of complexes with SNP. Thus,
in presence of an inhibitor (e.g., GMX1778 for NAMPT), the
color of the reaction medium will remain yellow because of the
reaction of NAM or NA with SNP, whereas in the absence of an
inhibitor, the reaction medium will become transparent. Hence,
the potency of the inhibitor tested could be easily measured
spectrophotometrically following the decrease in the absorbance
at 395 nm for NAM or 385 nm for NA.
CONCLUSION
We have developed two whole-cell methods for the screening
of metagenomic/polygenomic libraries to discover new enzymes
with balanced pyrazinamidase/nicotinamidase activities, using
for this purpose the chemical property of POA and NAs to form
colored complexes with the iron stable salts. After screening more
than 8000 clones in a fosmid polygenomic library, one positive
clone was selected with high and balanced nicotinamidase and
pyrazinamidase activities, which could be a good candidate for
biotechnological applications. In addition, its inhibition pattern
with different nicotinaldehydes has allowed us to develop a new
pre-screening method that could save time and costs in the search
of promising drugs to fight against bacterial and parasitic human
diseases (Lyme disease, Malta fever, malaria and infantile visceral
leishmaniasis). Finally, the method could be also applied to screen
for other enzymes with biomedical relevance that use NA or
NAM as a substrate.
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